Yuzi Zhang
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 13
- Colorectal Cancer Treatments and Studies 6
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 19
-
- Advanced Breast Cancer Therapies 5
- Ferroptosis and cancer prognosis 4
- Lung Cancer Treatments and Mutations 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
-
- RNA modifications and cancer 4
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Journal of Clinical Oncology (13 papers)Pathology & Oncology Research (3 papers)Cancer Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yuzi Zhang
42 papers receiving 789 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 568
- Cancer Research 188
- Immunology 176
- Pulmonary and Respiratory Medicine 187
- Pathology and Forensic Medicine 61
Countries citing papers authored by Yuzi Zhang
This map shows the geographic impact of Yuzi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzi Zhang more than expected).
Fields of papers citing papers by Yuzi Zhang
This network shows the impact of papers produced by Yuzi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzi Zhang. The network helps show where Yuzi Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuzi Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 26 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 20 | |
| 12 | 2019 | 18 | |
| 13 | 2019 | 18 | |
| 14 | Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancerbreakdown → | 2019 | 249 |
| 15 | 2019 | 1 | |
| 16 | 2018 | 20 | |
| 17 | [Effect of body mass index on disease-free and overall survival in Chinese women with breast cancer]. | 2015 | 2 |
| 18 | 2015 | 42 | |
| 19 | 2015 | 43 | |
| 20 | 2014 | 174 |
About Yuzi Zhang
Yuzi Zhang is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 797 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (19 papers), Cancer Immunotherapy and Biomarkers (13 papers), Colorectal Cancer Treatments and Studies (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Advanced Breast Cancer Therapies (5 papers), Ferroptosis and cancer prognosis (4 papers), Lung Cancer Treatments and Mutations (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Oncology (568 citations), Cancer Research (188 citations) and Immunology (176 citations). Yuzi Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Kunwei Shen, Qing Qu, Junjun Liu, Xiaosong Chen, Yan Mao, Shangli Cai, Zhengyi Zhao, Yuezong Bai, Xiaochen Zhao and Jing Zhao. Their work appears in journals such as Journal of Clinical Oncology, Pathology & Oncology Research, Cancer Medicine, Cancer Research and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.